The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior
Open accessAbstract
Symptoms of depression can be induced in humans through blockade of acetylcholinesterase (AChE) whereas antidepressant-like effects can be produced in animal models and some clinical trials by limiting activity of acetylcholine (ACh) receptors. Thus, ACh signaling could contribute to the etiology of mood regulation. To test this hypothesis, we administered the AChE inhibitor physostigmine to mice and demonstrated an increase in anxiety- and depression-like behaviors that was reversed by administration of nicotinic or muscarinic antagonists. The behavioral effects of physostigmine were also reversed by administration of the selective serotonin reuptake inhibitor fluoxetine. Administration of fluoxetine also increased AChE activity throughout the brain, with the greatest change in the hippocampus. To determine whether cholinergic signaling in the hippocampus could contribute to the systemic effects of cholinergic drugs, we infused physostigmine or virally delivered shRNAs targeting AChE into the hippocampus. Both pharmacological and molecular genetic decreases in hippocampal AChE activity increased anxiety- and depression-like behaviors and decreased resilience to repeated stress in a social defeat paradigm. The behavioral changes due to shRNA-mediated knockdown of AChE were rescued by coinfusion of an shRNA-resistant AChE transgene into the hippocampus and reversed by systemic administration of fluoxetine. These data demonstrate that ACh signaling in the hippocampus promotes behaviors related to anxiety and depression. The sensitivity of these effects to fluoxetine suggests that shRNA-mediated knockdown of hippocampal AChE represents a model for anxiety- and depression-like phenotypes. Furthermore, abnormalities in the cholinergic system may be critical for the etiology of mood disorders and could represent an endophenotype of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Increasing acetylcholine signaling in the hippocampus via local knockdown of acetylcholine esterase (AChE) results in increased avoidance of anxiogenic environments, in-creased immobility in response to inescapable stress, and decreased threshold for social defeat (Mineur et al. 2013).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Mineur et al. 2013
In the citing paper
“while increased ACh transmission can increase behaviors related to depression in humans (Risch et al., 1980) and rodents (Mineur et al., 2013), the type of circuits/cell types that are modulated by ACh or nAChRs can have opposite effects on mood regulation, and the outcome on behavior depends on the sum of these effects.”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
In the citing paper
“These results indicate that abnormal nicotinic signaling may underlie depression symptoms (Mineur et al., 2013; Tizabi et al., 2000)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES
Karnovsky, M. J., & ROOTS, L. (1964) · Journal of Histochemistry & Cytochemistry · doi:10.1177/12.3.219 · Cited by 3,368
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“To test whether manipulations of AChE could potentiate an animal’s susceptibility to psychosocial stress induced by repeated defeat, we also used the submaximal defeat paradigm as reported previously (43).”
MethodEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067589 · Cited by 1,437
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Self-citationA cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
Linking Molecules to Mood: New Insight Into the Biology of Depression
Krishnan, V., & Nestler, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.10030434 · Cited by 666
Acute stress facilitates long-lasting changes in cholinergic gene expression
Kaufer, D., Friedman, A., Seidman, S., & Soreq, H. (1998) · Nature · doi:10.1038/30741 · Cited by 588
Research works printed but not linked: 1
- 10.1037/0735-7044.112.2.352 · DOI
Cited by
Sorted by citations
Sarasamma, S., Audira, G., Siregar, P., Malhotra, N., Lai, Y., Liang, S., Chen, J., Chen, K. H. ‐., & Hsiao, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041410 · Cited by 477
Patki, G., Solanki, N., Atrooz, F., Allam, F., & Salim, S. (2013) · Brain Research · doi:10.1016/j.brainres.2013.09.033 · Cited by 380
Walczak, Ł. J., & Herbet, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179290 · Cited by 376
Fluorescent probes for the detection of disease-associated biomarkers
Dou, W., Han, H., Sedgwick, A. C., Zhu, G.-B., Zang, Y., Yang, X., Yoon, J., James, T. D., Li, J. X., & He, X. (2022) · 中国科学通报:英文版 · doi:10.1016/j.scib.2022.01.014 · Cited by 267
Wang, X., Li, P., Ding, Q., Wu, C., Zhang, W., & Tang, B. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11414 · Cited by 254
Defeat stress in rodents: from behavior to molecules
Hammels, C., Pishva, E., De Vry, J., van den Hove, D. L. A., Prickaerts, J., van Winkel, R., Selten, J.-P., Lesch, K.-P., Daskalakis, N. P., Steinbusch, H. W. M., et al. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.10.006 · Cited by 230
Bidirectional relationship between sleep and depression
Yasugaki, S., Okamura, H., Kaneko, A., & Hayashi, Y. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.04.006 · Cited by 231
Wood, S. K., & Bhatnagar, S. (2014) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.11.002 · Cited by 210
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics
Dulawa, S. C., & Janowsky, D. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0219-x · Cited by 187
Neuromodulation by acetylcholine: examples from schizophrenia and depression
Higley, M. J., & Picciotto, M. R. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.06.004 · Cited by 184
Self-citationDavis, M. T., Holmes, S. E., Pietrzak, R. H., & Esterlis, I. (2017) · Chronic Stress · doi:10.1177/2470547017710916 · Cited by 194
Mechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Self-citationPicciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., & Mineur, Y. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.028 · Cited by 157
Self-citationGABAergic Control of Depression-Related Brain States
Luscher, B., & Fuchs, T. (2015) · Advances in Pharmacology · doi:10.1016/bs.apha.2014.11.003 · Cited by 149
Basal forebrain cholinergic signalling: development, connectivity and roles in cognition
Ananth, M. R., Rajebhosale, P., Kim, R., Talmage, D. A., & Role, L. W. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00677-x · Cited by 148
Hippocampus: Molecular, Cellular, and Circuit Features in Anxiety
Shi, H., Wang, S., Wang, X., Zhang, R.-X., & Zhu, L. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01020-1 · Cited by 151
Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population
Faye, C., McGowan, J. C., Denny, C. A., & David, D. J. P. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170818095105 · Cited by 143
Behavioral and biochemical consequences of Danio rerio larvae exposure to polylactic acid bioplastic
de Oliveira, J. P. J., Estrela, F. N., Rodrigues, A. S. D. L., Guimarães, A. T. B., Rocha, T. L., & Malafaia, G. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124152 · Cited by 136
Setti-Perdigão, P., Serrano, M. A. R., Flausino, O., Bolzani, V. D. S., Guimarães, M. Z. P., & Castro, N. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082726 · Cited by 125
The Integrative Role of the Sigh in Psychology, Physiology, Pathology, and Neurobiology
Ramirez, J.-M. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63274-6.00006-0 · Cited by 120
Orozco-Solis, R., Montellier, E., Aguilar-Arnal, L., Sato, S., Vawter, M. P., Bunney, B. G., Bunney, W. E., & Sassone-Corsi, P. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.1176 · Cited by 119
Molecules and circuits involved in nicotine addiction: The many faces of smoking
Picciotto, M. R., & Mineur, Y. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.028 · Cited by 123
Self-citationChecks and balances on cholinergic signaling in brain and body function
Soreq, H. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.05.007 · Cited by 121
Normalization and the Cholinergic Microcircuit: A Unified Basis for Attention
Schmitz, T. W., & Duncan, J. (2018) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2018.02.011 · Cited by 119
Cholinergic nervous system and glaucoma: From basic science to clinical applications
Faiq, M. A., Wollstein, G., Schuman, J. S., & Chan, K. C. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.06.003 · Cited by 127
Sustained Effects of Rapidly Acting Antidepressants Require BDNF-Dependent MeCP2 Phosphorylation
Kim, J.-W., Autry, A. E., Na, E. S., Adachi, M., Björkholm, C., Kavalali, E. T., & Monteggia, L. M. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00868-8 · Cited by 113
The catecholaminergic–cholinergic balance hypothesis of bipolar disorder revisited
van Enkhuizen, J., Janowsky, D. S., Olivier, B., Minassian, A., Perry, W., Young, J. W., & Geyer, M. A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.063 · Cited by 111
Animal models for bipolar disorder: from bedside to the cage
Beyer, D. K. E., & Freund, N. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0104-6 · Cited by 113
The cancer-immune dialogue in the context of stress
Ma, Y., & Kroemer, G. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00949-8 · Cited by 121
Faster, better, stronger: Towards new antidepressant therapeutic strategies
O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 104
Zhang, C., Li, Y., Yu, H., Ye, L., Li, T., Zhang, X., Wang, C., Li, P., Ji, H., Gao, Q., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.161005 · Cited by 99
Competing targets of microRNA-608 affect anxiety and hypertension
Hanin, G., Shenhar‐Tsarfaty, S., Yayon, N., Yau, Y. H., Bennett, E. R., Sklan, E. H., Rao, D. C., Rankinen, T., Bouchard, C., Shochat, S. G., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu170 · Cited by 99
Ait-Bali, Y., Ba-M’hamed, S., Gambarotta, G., Sassoé‐Pognetto, M., Giustetto, M., & Bennis, M. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02677-7 · Cited by 102
Schmidel, A. J., Assmann, K. L., Werlang, C. C., Bertoncello, K. T., Franscescon, F., Rambo, C. L., Beltrame, G. M., Calegari, D., Batista, C. B., Blaser, R. E., et al. (2014) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.05.006 · Cited by 99
Xu, W., Cai, X., Wu, Y., Wen, Y., Su, R., Zhang, Y., Huang, Y., Zheng, Q., Hu, L., Cui, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41765-x · Cited by 94
An epigenetic mechanism mediates developmental nicotine effects on neuronal structure and behavior
Jung, Y., Hsieh, L. S., Lee, A. M., Zhou, Z., Coman, D., Heath, C. J., Hyder, F., Mineur, Y. S., Yuan, Q., Goldman, D., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4315 · Cited by 90
Self-citationMineur, Y. S., Fote, G. M., Blakeman, S., Cahuzac, E. L. M., Newbold, S. A., & Picciotto, M. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.316 · Cited by 90
Self-citationNeurochemical and behavioral analysis by acute exposure to bisphenol A in zebrafish larvae model
Kim, S. S., Hwang, K.-S., Yang, J. Y., Chae, J. S., Kim, G. R., Kan, H., Jung, M. H., Lee, H.-Y., Song, J. S., Ahn, S., et al. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.124751 · Cited by 84
Liu, H., Zhang, X., Shi, P., Yuan, J., Jia, Q., Pi, C., Chen, T., Xiong, L., Chen, J., Tang, J., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02768-z · Cited by 88
Pittman, M. E., Edwards, S. W., Ives, C., & Mortensen, H. M. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.02.006 · Cited by 78
The role of acetylcholine in negative encoding bias: Too much of a good thing?
Mineur, Y. S., & Picciotto, M. R. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14641 · Cited by 78
Self-citationDai, W., Feng, K., Sun, X., Xu, L., Wu, S., Rahman, K., Jia, D. T., & Han, T. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114692 · Cited by 81
Hirano, T., Yanai, S., Takada, T., Yoneda, N., Omotehara, T., Kubota, N., Minami, K., YAMAMOTO, A., MANTANI, Y., YOKOYAMA, T., et al. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.10.010 · Cited by 82
Fernandez, S. P., Broussot, L., Marti, F., Contesse, T., Mouska, X., Soiza-Reilly, M., Marie, H., Faure, P., & Barik, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06809-7 · Cited by 75
Moreno-Rius, J. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100774 · Cited by 77
Cytisine and cytisine derivatives. More than smoking cessation aids
Gotti, C., & Clementi, F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105700 · Cited by 86
Altered food-cue processing in chronically ill and recovered women with anorexia nervosa
Sanders, N., Smeets, P. A. M., van Elburg, A. A., Danner, U. N., van Meer, F., Hoek, H. W., & Adan, R. A. H. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00046 · Cited by 72
“The hippocampus is involved in contextual memory and associated with anxiety and depression (Nunn et al., 2008; Mineur et al., 2013).”
BackgroundMineur, Y. S., Mose, T. N., Blakeman, S., & Picciotto, M. R. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13769 · Cited by 71
Self-citationMineur, Y. S., Cahuzac, E. L. M., Mose, T. N., Bentham, M. P., Plantenga, M. E., Thompson, D. C., & Picciotto, M. R. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0024-x · Cited by 71
Self-citationThe Role of the Medial Habenula Cholinergic System in Addiction and Emotion-Associated Behaviors
Lee, H. W., Yang, S. H., Kim, J. Y., & Kim, H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00100 · Cited by 73
Investigating the mechanism(s) underlying switching between states in bipolar disorder
Young, J. W., & Dulcis, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.019 · Cited by 68
Suarez-Lopez, J. R., Hood, N. R., Suárez-Torres, J., Gahagan, S., Gunnar, M. R., & López-Paredes, D. (2019) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2019.06.001 · Cited by 72
Papp, M., Gruca, P., Łasoń, M., & Willner, P. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4206-0 · Cited by 72
Ma, Y., Gao, W., Ma, S., Liu, Y., & Lin, W. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02770 · Cited by 67
Umukoro, S., Kalejaye, H. A., Ben‐Azu, B., & Ajayi, A. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.016 · Cited by 67
Depression and substance use disorders: Clinical comorbidity and shared neurobiology
Calarco, C. A., & Lobo, M. K. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.004 · Cited by 74
Self-citationFerlemi, A.-V., Katsikoudi, A., Kontogianni, V. G., Kellici, T. F., Iatrou, G., Lamari, F. N., Tzakos, A. G., & Margarity, M. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.013 · Cited by 65
Limon, A., Mamdani, F., Hjelm, B. E., Vawter, M. P., & Sequeira, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.010 · Cited by 63
Gupta, S. C., Yadav, R., Pavuluri, R., Morley, B. J., Stairs, D. J., & Dravid, S. M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.013 · Cited by 70
Zhang, J.-C., Yao, W., Ren, Q., Yang, C., Dong, C., Ma, M., Wu, J., & Hashimoto, K. (2016) · Scientific Reports · doi:10.1038/srep36705 · Cited by 67
Down-regulation of cholinergic signaling in the habenula induces anhedonia-like behavior
Han, S., Yang, S. H., Kim, J. Y., Mo, S., Yang, E., Song, K. M., Ham, B., Mechawar, N., Turecki, G., Lee, H. W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01088-6 · Cited by 67
Ji, Y., Shen, Z.-L., Zhang, X., Zhang, K., Jia, T., Xu, X., Geng, H., Han, Y., Cui, Y., Yang, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37968-x · Cited by 69
Pandya, A. A., & Yakel, J. L. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.018 · Cited by 65
Zhang, Y., Cao, S.-X., Sun, P., He, H.-Y., Yang, C.-H., Chen, X., Shen, C.-J., Wang, X., Chen, Z., Berg, D. K., et al. (2016) · Cell Research · doi:10.1038/cr.2016.48 · Cited by 62
Allen, J., Caruncho, H. J., & Kalynchuk, L. E. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.010 · Cited by 62
Zhao, C., Zhang, H., Li, H., Lv, C., Liu, X., Li, Z., Xin, W., Wang, Y., & Zhang, W. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.002 · Cited by 59
Zhang, H., Zhang, S., Hu, M., Chen, Y., Wang, W., Zhang, K., Kuang, H., & Wang, Q. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113435 · Cited by 59
Molecularly defined and functionally distinct cholinergic subnetworks
Li, X., Yu, H., Zhang, B., Li, L., Chen, W., Yu, Q., Huang, X., Xiao, K., Wang, Y., Jing, W., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.08.025 · Cited by 58
Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agents
Cásedas, G., Moliner, C., Maggi, F., Mazzara, E., & López, V. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1009868 · Cited by 56
Neuroligin 2 Is Expressed in Synapses Established by Cholinergic Cells in the Mouse Brain
Takács, V. T., Freund, T. F., & Nyíri, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072450 · Cited by 56
Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors
Yu, L.-F., Zhang, H.-K., Caldarone, B. J., Eaton, J. B., Lukas, R. J., & Kozikowski, A. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401937a · Cited by 56
Striatal Cholinergic Interneurons Are a Novel Target of Corticotropin Releasing Factor
Lemos, J. C., Shin, J. H., & Alvarez, V. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0479-19.2019 · Cited by 59
The adaptive and maladaptive continuum of stress responses – a hippocampal perspective
Suri, D., & Vaidya, V. A. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0083 · Cited by 66
Melatonin Protects Against Diazinon-Induced Neurobehavioral Changes in Rats
Ahmed, M. A. E., Ahmed, H. I., & Morsy, E. M. E. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1134-9 · Cited by 51
Antidepressant effects of curcumin-coated iron oxide nanoparticles in a rat model of depression
Khadrawy, Y. A., Hosny, E. N., Magdy, M., & Mohammed, H. S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174384 · Cited by 51
Lithium prevents scopolamine-induced memory impairment in zebrafish
Zanandrea, R., de Abreu, M. S., Piato, Â., Barcellos, L. J. G., & Giacomini, A. C. V. V. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.010 · Cited by 53
Söderlund, J., & Lindskog, M. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy037 · Cited by 54
Oladapo, O. M., Ben‐Azu, B., Ajayi, A. M., Emokpae, O., Eneni, A.-E. O., Omogbiya, I. A., & Iwalewa, E. O. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01664-y · Cited by 51
Luo, G., Wei, R., Niu, R., Wang, C., & Wang, J. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.037 · Cited by 50
Mineur, Y. S., Mose, T. N., Vanopdenbosch, L., Etherington, I. M., Ogbejesi, C., Islam, A., Pineda, C. M., Crouse, R. B., Zhou, W., Thompson, D. C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01404-7 · Cited by 48
Self-citationThe hippocampus in stress susceptibility and resilience: Reviewing molecular and functional markers
Larosa, A., & Wong, T. P. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110601 · Cited by 50
Xu, L., Dong, W., Zhao, J., & Xu, Y. (2015) · Marine Drugs · doi:10.3390/md13063653 · Cited by 48
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis
Chana, G., Bousman, C., Money, T., Gibbons, A. S., Gillett, P., Dean, B., & Everall, I. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00095 · Cited by 44
Giacomini, A. C. V. V., Bueno, B. W., Marcon, L., Scolari, N., Genário, R., Demin, K. A., Kolesnikova, T. O., Kalueff, A. V., & de Abreu, M. S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120944155 · Cited by 48
Bredemann, T. M., & McMahon, L. L. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.004 · Cited by 43
van Enkhuizen, J., Milienne-Petiot, M., Geyer, M. A., & Young, J. W. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4000-4 · Cited by 46
Wang, J., Cheng, C., Xin, C., & Wang, Z. (2019) · Molecules · doi:10.3390/molecules24061105 · Cited by 44
Small, K. M., Nunes, E., Hughley, S., & Addy, N. A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.057 · Cited by 43
Anxiolytic-like, stimulant and neuroprotective effects of Ilex paraguariensis extracts in mice
Santos, E. C. S., Bicca, M. A., Blum-Silva, C. H., Costa, A. P., dos Santos, A. A., Schenkel, E. P., Farina, M., Reginatto, F. H., & de Lima, T. C. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.004 · Cited by 44
Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test
Addy, N. A., Nunes, E. J., & Wickham, R. J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.002 · Cited by 42
Pathophysiology of nAChRs: Limbic circuits and related disorders
Mineur, Y. S., Soares, A. R., Etherington, I. M., Abdulla, Z. I., & Picciotto, M. R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106745 · Cited by 42
Self-citationVerplaetse, T. L., Weinberger, A. H., Smith, P. H., Cosgrove, K., Mineur, Y. S., Picciotto, M. R., Mazure, C. M., & McKee, S. A. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu280 · Cited by 41
Self-citationSocial defeat stress: Mechanisms underlying the increase in rewarding effects of drugs of abuse
Montagud‐Romero, S., Blanco-Gandía, M. C., Reguilón, M. D., Perez, C. F., Ballestín, R., Miñarro, J., & Rodríguez‐Arias, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14127 · Cited by 40
Liu, S., Yu, M., Xie, X., Ru, Y., & Ru, S. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126635 · Cited by 41
Bentz, A. B., George, E., Wolf, S. E., Rusch, D. B., Podicheti, R., Buechlein, A. M., Nephew, K. P., & Rosvall, K. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016154118 · Cited by 38
Qiu, X., Chen, C., Shi, Y., Chen, K., Li, M., Xu, H., Wu, X., Takai, Y., Shimasaki, Y., & Oshima, Y. (2022) · Aquatic Toxicology · doi:10.1016/j.aquatox.2022.106129 · Cited by 41
Bhattacharya, S., Maelicke, A., & Montag, D. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142421 · Cited by 39
Zhang, L., Wu, C., Martel, D. T., West, M., Sutton, M. A., & Shore, S. E. (2018) · Hippocampus · doi:10.1002/hipo.23058 · Cited by 38
Boyacı, E., Lendor, S., Bojko, B., Reyes‐Garcés, N., Gómez‐Ríos, G. A., Olkowicz, M., Diwan, M., Palmer, M., Hamani, C., & Pawliszyn, J. B. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00274 · Cited by 39
Resilience to the effects of social stress on vulnerability to developing drug addiction
Calpe-López, C., Martínez-Caballero, M. Á., García-Pardo, M. P., & Aguilar, M. A. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i1.24 · Cited by 38
Metadata
- Authors
- Mineur, Y. S., Obayemi, A., Wigestrand, M. B., Fote, G. M., Calarco, C. A., Li, A. M., & Picciotto, M. R.
- Affiliations
- Yale University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-02-11
- Volume
- 110
- Issue
- 9
- Pages
- 3573-3578
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3587265
- OpenAlex
- W2020386906
- Cited by
- 375
- References
- 46
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 21 · 2023: 24 · 2022: 38 · 2021: 34 · 2020: 38 · 2019: 30 · 2018: 33 · 2017: 20 · 2016: 24 · 2015: 27 · 2014: 18 · 2013: 15
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DA033945)
- National Institute of Mental Health (MH077681, R01MH077681)
- National Institute on Drug Abuse (P50DA033945, DA033945)
- National Institute of General Medical Sciences (T32GM007205)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- cholinergic neurotransmission, hippocampus, acetylcholinesterase, physostigmine, anxiety-like behavior, depression-like behavior, social defeat, fluoxetine, nicotinic acetylcholine receptors, muscarinic receptors, shRNA knockdown, mood disorders
- MeSH terms
- Acetylcholinesterase, Dependovirus, Animals, Antidepressive Agents, Anxiety, Behavior, Animal, Depression, Fluoxetine, Hippocampus, Humans, Male, Mice, Inbred C57BL, Phenotype, Physostigmine, Receptors, Cholinergic, Stress, Psychological, Time Factors, Signal Transduction, Cholinergic Antagonists, Hindlimb Suspension, RNA, Small Interfering, Mice, Resilience, Psychological, Gene Knockdown Techniques, Cholinergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review